Ontvang nu dagelijks onze kooptips!

word abonnee
IEX 25 jaar
Uitgebreid zoeken

Beurscodes, betekenis en hulp bij zoeken

Europa

AEX
Euronext Amsterdam
BRU
Euronext Brussels
PSE
Euronext Paris
LIS
Euronext Lissabon
CHX
CBOE Europe, grote(re) EU aandelen
NAV
Investment Funds (NAV)

Noord-Amerika

NYS
New York Stock Exchange
OTC
CBOE BZX Exchange (US)
TSE
Toronto Stock Exchange

Kunt u een instrument niet vinden?

Zoek dan via de zogenaamde ISIN code. Elk instrument, aandeel etc. heeft een unieke code.

Kies vervolgens - wanneer er meerdere resultaten zijn - de notering op de beurs van uw keuze.

Waar vind ik die ISIN code?

Google de naam van het instrument, aandeel etc. met de toevoeging 'ISIN'.

Als zoeken op ISIN code geen resultaten oplevert hebben wij het instrument of aandeel niet in onze koersendatabase.

desktop iconMarkt Monitor
Markt vandaag Koersen Forum Premium IEX Expert
Home  /   Forum   /   Galapagos   /   KOERS GALAPAGOS 2015

Aandeel Galapagos AEX:GLPG.NL, BE0003818359

Laatste koers (eur) Verschil Volume
23,960   -0,980   (-3,93%) Dagrange 23,680 - 24,740 222.716   Gem. (3M) 110,3K

KOERS GALAPAGOS 2015

Volgen
16.480 Posts
Pagina: «« 1 ... 195 196 197 198 199 ... 824 »» | Laatste | Omlaag ↓
  1. [verwijderd] 24 april 2015 17:45
    quote:

    Bolknak_26F5 schreef op 24 april 2015 17:34:

    Re. SJURVM
    "Amount to be registered", not the amount to offered to the market, I think
    Yes but the potential of having it all issued is therefore there.

    Why go for 100m shares worth $3.5b if you are looking only for $150 million as per form 1 originally?

    OK, may be you wish to have a little "flexibility" on the upside if the placing goes really well. So you don't want to limit the number of shares too tightly.

    I know that to avoid registration cost you might also like to have more registered than what you intend to issue. But up to $3.5b??

    What else is cooking?

  5. [verwijderd] 24 april 2015 17:59
    quote:

    SJURVM schreef op 24 april 2015 16:41:

    American Depositary Shares (ADS(s)), each ADS representing the right to receive one (1) ordinary share of Galapagos NV
    Amount to be registered 100,000,000 ADSs

    Am I going crazy or if you read this form F-6 it tells you that 100m ADS represents 100 m ord share Galapagos.

    Say at $35/share (roughly €32.34) We are talking of $3.5 billion?????

    I need a stiff drink!

    From sec-gov site:
    -------------------------
    An ADR evidences one or more Depositary Shares, as defined in Rule 405 (§230.405 of this chapter). The registration statement relates to Depositary Shares, not the number of physical certificates issued.
    ---------------------------------

    So this does not indicate the actual number of shares/ADRs to be issued now, nor at what price that will take place.

    In essence any price can be attached to the actual shares/ADR's to be issued and the number of ADR's to be issued is maximized at 100 million.

    The intention is to raise on Nasdaq EUR 100 million at a price as yet to be set.
    Next to this placement there will be a private placement of EUR 50 million to eligible investors (read: current major shareholders), who can avoid dilution of their percentage held.

    If the price would be EUR 50 then we would get 3,000,000 additional shares issued of which 2,000,000 listed in the US.
    However if the price would be EUR 100 we would get only 1,500,000 shares issued of which 1,000,000 shares on Nasdaq.

    We will have to wait and see when and at what price the listing would take place. Market appetite will probably be verified once the monotest results are there.

    Actually I expect a further price appreciation and also an issue price above the Euronext price level, as parties will realize that there will be limited numbers of shares to be acquired on Nasdaq.

  7. [verwijderd] 24 april 2015 18:11
    What I don't understand is that if the authorised share capital of Galapagos is under $200 million why indidcating that it can potentially go to $3.5b?
    I know that there is no EGM to increase the share capital and that at present under the 2011 plan there is something like +-€110m still available after the exercising of the warrants by Management.

    So I am curious

  8. [verwijderd] 24 april 2015 18:27
    quote:

    SJURVM schreef op 24 april 2015 18:11:

    What I don't understand is that if the authorised share capital of Galapagos is under $200 million why indidcating that it can potentially go to $3.5b?
    I know that there is no EGM to increase the share capital and that at present under the 2011 plan there is something like +-€110m still available after the exercising of the warrants by Management.

    So I am curious


    When comparing to Vertex Gala still has to catch up quite a bit in issuances of shares.
    Roughly calculating they have 242 million shares issued.

    Vertex has net equity of USD 1.3 billion and a market value of USD 32.5 billion and a net loss of USD 739 million in 2014.
    The milestones alone for 634 will increase the equity of Galapagos above the USD 1.3 billion equity of Vertex.

  12. [verwijderd] 24 april 2015 21:22
    quote:

    MtBaker schreef op 24 april 2015 18:58:

    *

    Each unit represents 100 ADSs.

    Yes the small print

    [...]
    Yes, saw that a minute later.

    just curious on the amount of shares to be "registered".
    100 million authorised shares when in truth the maximum for the Nasdaq issue we are really talking about is roughly 3 million to be issued.

    Any thoughts?
  13. Sjefke7 24 april 2015 23:15
    quote:

    SJURVM schreef op 24 april 2015 21:22:

    [...]

    Yes, saw that a minute later.

    just curious on the amount of shares to be "registered".
    100 million authorised shares when in truth the maximum for the Nasdaq issue we are really talking about is roughly 3 million to be issued.

    Any thoughts?
    Could it be some sort of anti take-over measure?
  15. MtBaker 24 april 2015 23:31
    quote:

    SJURVM schreef op 24 april 2015 21:22:

    [...]

    Yes, saw that a minute later.

    just curious on the amount of shares to be "registered".
    100 million authorised shares when in truth the maximum for the Nasdaq issue we are really talking about is roughly 3 million to be issued.

    Any thoughts?
    They see a bright future and may want to make preparation for longer term even if it is not used. We have a small company and even that is set up so that you can easily introduce more shares and even different types as anticipation for an unknown future.
  18. [verwijderd] 25 april 2015 10:27
    quote:

    hoebeet schreef op 25 april 2015 09:04:

    Hoppetee! Royalty's oplopend tot in de 20%!

    Dit is nieuw voor mij. Heb ik wat gemist?
    Dat gaat menig rekensommetje verdubbelen! Let op niet alleen voor RA maar ook voor CF staat 20% genoemd. Het rekensommetje van Abbvie voor overname wordt ook steeds eenvoudiger, dat is de keerzijde.
    Strategie van GLPG om aandeelhouders verder wakker te schudden, het stand alone potentieel versus overname krijgt wat mij betreft een factor 2 mee, ik had ook 10% staan.
    Met 2 mld omzet filgotinib, 400 mln inkomsten GLPG. k/w 15 geeft koers €200. Bij montherapie, ach geef het een omzetverwachting van 5 mld.
    Zelfde sommetje:
    5 mld omzet filgotinib, 1 mld inkomsten GLPG. k/w 15 geeft koers € 500.

    Ik ben nog niet wakker.
  19. [verwijderd] 25 april 2015 10:51
    quote:

    stappa schreef op 25 april 2015 10:27:

    [...]

    Dat gaat menig rekensommetje verdubbelen! Let op niet alleen voor RA maar ook voor CF staat 20% genoemd. Het rekensommetje van Abbvie voor overname wordt ook steeds eenvoudiger, dat is de keerzijde.
    Strategie van GLPG om aandeelhouders verder wakker te schudden, het stand alone potentieel versus overname krijgt wat mij betreft een factor 2 mee, ik had ook 10% staan.
    Met 2 mld omzet filgotinib, 400 mln inkomsten GLPG. k/w 15 geeft koers €200. Bij montherapie, ach geef het een omzetverwachting van 5 mld.
    Zelfde sommetje:
    5 mld omzet filgotinib, 1 mld inkomsten GLPG. k/w 15 geeft koers € 500.

    Ik ben nog niet wakker.
    Die EUR 5 mld was bij Galapagos bij de koffie nog EUR 4 mld zonder monotherapie.
    In de rekensom nog wel 6.8% belasting eraf halen.
16.480 Posts
Pagina: «« 1 ... 195 196 197 198 199 ... 824 »» | Laatste |Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met je emailadres en wachtwoord.

Direct naar Forum

Premium

Galapagos meldt fraai succes rond nieuwe therapie: zit er weer muziek in het aandeel?

Het laatste advies leest u als abonnee van IEX Premium

Inloggen Word Abonnee

Galapagos Nieuws

  1. Kepler Cheuvreux zet Galapagos op verkooplijst
  2. Klinische resultaten Galapagos steunen celtherapie-hypothese
  3. Deutsche Bank verlaagt koersdoel Galapagos
  4. Financials en Shell doen goede zaken op terughoudend Damrak
  5. Galapagos herhaalt cash burn voor 2024
  6. Galapagos benoemt investeerder Nodelman in bestuur
  7. EcoR1 nog groter in Galapagos
  8. EcoR1 groter in Galapagos
  9. FMR LLC kleiner in Galapagos
  10. EcoR1 meldt belang in Galapagos